Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2018-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the correlation between pulmonary IV-OCT and pulmonary IV-US measurements and standard PAH clinical measures of disease progression and the relative sensitivity of the techniques to change.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Role of Intracoronary Imaging in Plaque Identification

NCT03953040

Coronary Artery Disease

WITHDRAWN

Association Between IVUS and OCT Parameters and Invasive Physiologic Indices

NCT03795714

Ischemic Heart Disease

UNKNOWN

Evaluation of Imaging of Peripheral Arteries by Optical Coherence Tomography and Intravascular Ultrasound Imaging

NCT03480685

Peripheral Artery Disease

COMPLETED NA

Does Optical Coherence Tomography Optimise Results of Stenting

NCT01743274

Acute Coronary Syndromes

COMPLETED NA

Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging

NCT02984891

Coronary Artery Disease (CAD)

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Arterial Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pulmonary Arterial Hypertension

Patients with Pulmonary Arterial Hypertension

Group Type EXPERIMENTAL

Patients with Pulmonary Arterial Hypertension

Intervention Type PROCEDURE

2 repeated measurement session to enable assessment of technical and medium-term reproducibility of IV-US and IV-OCT.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patients with Pulmonary Arterial Hypertension

2 repeated measurement session to enable assessment of technical and medium-term reproducibility of IV-US and IV-OCT.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* With confirmed diagnosis of PAH Group 1 according to the ESC/ERS Guidelines
* With severe disease, defined as Class II- III of the modified WHO functional classes in the ESC/ERS Guidelines